Open Access 01-12-2014 | Research article
Elective orthopedic and cardiopulmonary bypass surgery causes a reduction in serum endostatin levels
Published in: European Journal of Medical Research | Issue 1/2014
Login to get accessAbstract
Background
Endostatin is an endogenous inhibitor of angiogenesis that inhibits neovascularisation. The aim of the study was to evaluate the effect of elective surgery on endostatin levels.
Methods
Blood samples were collected prior to elective surgery and 4 and 30 days postoperatively in 2 patient groups: orthopedic surgery (n =27) and coronary bypass patients (n =21). Serum endostatin levels were measured by ELISA.
Results
Serum endostatin was significantly reduced 30 days after surgery in comparison with presurgical values in both the orthopedic (P =0.03) and cardiopulmonary surgery (P =0.04) group.
Conclusion
Serum endostatin is reduced 30 days after surgery. This reduction would favor angiogenesis and wound-healing.